Philip D. Worboys, SVP, Translational Science at Theravance Biopharma, Inc. (TBPH), sold 12,786 shares at $28.50 ($364K) on 2018-09-12, disclosed to the SEC on 2018-09-14.
Open-market sale of $364k TBPH by SVP, Translational Science. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.50 | 6,393 | $182K | 50.0% |
| 2 | $28.50 | 6,393 | $182K | 50.0% |
| Total | $28.50 avg | 12,786 | $364K | 100% |
| Filing → |
| TBPH | SELL | 2020-08-24 | $308K | — | Filing → |